The aim of this study was to evaluate the relationship between platelet-lymphocyte ratio (PLR) and first pass effect (FPE) in patients with acute ischemic stroke (AIS). Our secondary goal was to investigate other laboratory, demographic or technical parameters that may be related to FPE and to search for independent predictors of FPE.
Materials and methods
Patients who underwent mechanical thrombectomy (MT) in our hospital between January 2017 and February 2020 were reviewed. Patients were divided into two groups: FPE and non-FPE. Demographic features, laboratory parameters, pretreatment imaging and clinical features, angiographic and clinical outcomes were recorded and compared between the two groups. Logistic regression analysis was performed to analyze the independent predictors and a predictive model was produced for demonstrating the possibility to achieve FPE.
Results
The study consisted of 83 patients (37 female, 46 male; mean age 62.69 ± 15.16) who were treated by MT. FPE was achieved in 32 patients (32/83, 38.6%). PLR was higher in the non-FPE group (195.35 ± 101.49) when compared to the FPE group (103.17 ± 37.06). A PLR value of <126.3 and female sex were found as independent predictors of FPE. Our predictive model estimated the chance of FPE as 77.9% in female patients who had PLR values lower than 126.3 while it was 77.1% when only using the PLR cutoff value.
Conclusions
High levels of PLR were associated with the failure of FPE. High values of PLR may be considered as a negative predictor for FPE achievement prior to MT in patients with AIS.
MeschiaJFBushnellCBoden-AlbalaB, et al.; Council on Hypertension.
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American heart association/American stroke association. Stroke2014;
45: 3754–3832.
2.
GoyalMMenonBKvan ZwamWH, et al.
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet2016;
23; 387: 1723–1731.
3.
NogueiraRGLutsepHLGuptaR, et al.
Trevo versus merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet2012;
380: 1231–1240.
4.
SaverJLJahanRLevyEI, et al.
Solitaire flow restoration device versus the merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet2012;
380: 1241–1249.
5.
TurkASFreiDFiorellaD, et al.
ADAPT FAST study: a direct aspiration first pass technique for acute stroke thrombectomy. J Neurointerv Surg2018;
10: i4–i7.
6.
Delgado AlmandozJEKayanYYoungML, et al.
Comparison of clinical outcomes in patients with acute ischemic strokes treated with mechanical thrombectomy using either solumbra or ADAPT techniques. J Neurointerv Surg2016;
8: 1123–1128.
7.
RhaJHSaverJL.The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke2007;
38: 967–973.
8.
TomsickTAYeattsSDLiebeskindDS, et al.; IMS III Investigators.
Endovascular revascularization results in IMS III: intracranial Ica and M1 occlusions. J Neurointerv Surg2015;
7: 795–802.
9.
AraiDIshiiAChiharaH, et al.
Histological examination of vascular damage caused by stent retriever thrombectomy devices. J Neurointerv Surg2016;
8: 992–995.
10.
LinfanteIStarosciakAKWalkerGR, et al.
Predictors of poor outcome despite recanalization: a multiple regression analysis of the NASA registry. J Neurointerv Surg2016;
8: 224–229.
11.
ZaidatOOCastonguayACLinfanteI, et al.
First pass effect: a new measure for stroke thrombectomy devices. Stroke2018;
49: 660–666.
12.
NikoubashmanODekeyzerSRiabikinA, et al.
True first-pass effect. Stroke2019;
50: 2140–2146.
13.
MarnatGBarreauXDetrazL, ETIS Investigatorset al.
First-line Sofia aspiration thrombectomy approach within the endovascular treatment of ischemic stroke multicentric registry: efficacy, safety, and predictive factors of success. AJNR Am J Neuroradiol2019;
40: 1006–1012.
14.
MausVBehmeDKabbaschC, et al.
Maximizing first-pass complete reperfusion with SAVE. Clin Neuroradiol2018;
28: 327–338.
15.
BaltaSDemırkolSKucukU.The platelet lymphocyte ratio may be useful inflammatory indicator in clinical practice. Hemodial Int2013;
17: 668–669.
16.
Kan E, Emektar E, Corbacioglu K, et al. Evaluation of relationship between inflammatory markers and hyperemesis gravidarum in patients admitted to emergency department. Am J Emerg Med 2020; 38: 292–295.
17.
AltintasOAltintasMOTasalA, et al.
The relationship of platelet-to-lymphocyte ratio with clinical outcome and final infarct core in acute ischemic stroke patients who have undergone endovascular therapy. Neurol Res2016;
38: 759–765.
18.
SariogluOCaparAEBeletU.Relationship of arteriovenous fistula stenosis and thrombosis with the platelet-lymphocyte ratio in hemodialysis patients. J Vasc Access2020;
21: 630–635.
19.
DrieuALevardDVivienD, et al.
Anti-inflammatory treatments for stroke: from bench to bedside. Ther Adv Neurol Disord2018;
11: 1756286418789854.
20.
ThomallaGGerloffC.Treatment concepts for wake-up stroke and stroke with unknown time of symptom onset. Stroke2015;
46: 2707–2713.
21.
DemchukAMGoyalMMenonBK, et al.; ESCAPE Trial Investigators.
Endovascular treatment for small core and anterior circulation proximal occlusion with emphasis on minimizing CT to recanalization times (ESCAPE) trial: methodology. Int J Stroke2015;
10: 429–438.
22.
SingerOCBerkefeldJNolteCH, et al.; ENDOSTROKE Study Group.
Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study. Ann Neurol2015;
77: 415–424.
23.
ShiZSLiebeskindDSXiangB, et al.; Multi MERCI, TREVO, and TREVO 2 Investigators.
Predictors of functional dependence despite successful revascularization in large-vessel occlusion strokes. Stroke2014;
45: 1977–1984.
24.
ZaidatOOYooAJKhatriP, et al.; STIR Thrombolysis in Cerebral Infarction (TICI) Task Force.
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke2013;
44: 2650–2663.
25.
WahlgrenNAhmedNDávalosA, et al.; SITS-MOST investigators.
Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in Stroke-Monitoring study (SITS-MOST): an observational study. Lancet2007;
369: 275–282.
26.
NogueiraRGLiebeskindDSSungG, et al.
Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the mechanical embolus removal in cerebral ischemia (MERCI) and multi MERCI trials. Stroke2009;
40: 3777–3783.
27.
KaplanZSJacksonSP.The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program2011;
2011: 51–61.
28.
HorneBDAndersonJLJohnJM, et al.
Which white blood cell subtypes predict increased cardiovascular risk?J Am Coll Cardiol2005;
45: 1638–1643.
29.
KimJYParkJChangJY, et al.
Inflammation after ischemic stroke: the role of leukocytes and glial cells. Exp Neurobiol2016;
25: 241–251.
30.
TemizAGaziEGüngörÖ, et al.
Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit2014;
20: 660–665.
31.
GaryTPichlerMBelajK, et al.
Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One2013;
8: e67688.
32.
AzabBShahNAkermanM, et al.
Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis2012;
34: 326–334.
33.
Douglas A, Fitzgerald S, Mereuta OM, et al. Platelet-rich emboli are associated with von Willebrand factor levels and have poorer revascularization outcomes. J Neurointerv Surg 2020; 12: 557–562.
34.
Velasco GonzalezAGörlichDBuerkeB, et al.
Predictors of successful first-pass thrombectomy with a balloon guide catheter: results of a decision tree analysis. Transl Stroke Res2020;
11: 900–909.
35.
HammadMShehataOZAbdel-LatifSM, et al.
Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet's disease: which and when to use?Clin Rheumatol2018;
37: 2811–2817.
36.
TurkmenKErdurFMOzcicekF, et al.
Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int2013;
17: 391–396.
37.
YaprakMTuranMNDayananR, et al.
Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients. Int Urol Nephrol2016;
48: 1343–1348.
38.
Di MariaFKyhengMConsoliA, et al.
Identifying the predictors of first-pass effect and its influence on clinical outcome in the setting of endovascular thrombectomy for acute ischemic stroke: results from a multicentric prospective registry. Int J Stroke2020;
7: 1747493020923051.
39.
RiedelCHZimmermannPJensen-KonderingU, et al.
The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke2011;
42: 1775–1777.
